Latest filing published 01 May 2025 for HCA Healthcare, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Dennis sold 8 times and bought twice; purchases weigh 20% of market trades. The two purchases, both at Genesco Inc, are EUR 395,335 on September 5, 2017 and EUR 103,750 the next day, EUR 499,084 together. Sales total EUR 4,628,934, median EUR 472,311, with EUR 954,048 on December 6, 2016, EUR 890,382 on March 15, 2016 and EUR 573,043 on June 9, 2016, three times at Genesco Inc.
The 40 filings, from February 22, 2016 to May 1, 2025, split between Genesco Inc (19, title Chairman, President & CEO), CoreCivic, Inc. (11, Director, including one sale) and HCA Healthcare, Inc. (10, Director). The record holds 29 grants and one option exercise. The year 2016 is the densest with 9 filings; from 2021 on, 2 or 3 remain each year. Nothing falls in the last twelve months.
Dennis has 4, 3 and 2 own market trades within 30 days of colleagues at Genesco Inc, in that order. All on the same side. Colleagues in order: Mimi Eckel Vaughn, Marty G. Dickens and Kathleen Mason.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations